Epitomee Medical Ltd Aktie - Unternehmensdaten & Kurse - IL0011825911 | goSPATZ

Epitomee Medical Ltd

Share · IL0011825911 (XTAE)

No Price

Closing Price XTAE 21.12.2025: 682,40 ILA

21.12.2025 13:49

Current Prices from Epitomee Medical Ltd

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
TASE	EPIT.TA	ILA	21.12.2025 13:49	682,40 ILA	27,40 ILA +4,18 %

Share Float & Liquidity

Free Float 100,00 %

Shares Float 30,07 M

Shares Outstanding 30,07 M

Company Profile for Epitomee Medical Ltd Share

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.

AI Analysis of Epitomee Medical Ltd

Click any analysis below to get instant AI insights from finAgent

Company Data

Name Epitomee Medical Ltd

Company Epitomee Medical Ltd

Website https://www.epitomeemedical.com

Primary Exchange

TASE

ISIN IL0011825911

Asset Class Share

Sector Healthcare

Industry Medical - Devices

CEO Radan Hashimshony

Market Capitalization 197 Mio

Country Israel

Currency ILA

Employees 0,0 T

Address 19 Tarshish, 3088900 Caesarea

IPO Date 2021-12-15

Ticker Symbols

Name	Symbol
TASE	EPIT.TA

More Shares

Investors who hold Epitomee Medical Ltd also have the following shares in their portfolio:

ALPS Clean Energy ETF ETF

Maj Invest Grønne Obligationer Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025